Study Purpose:
Autoimmune encephalitis (AE) and paraneoplastic neurological syndromes (PNS) are rare disease that could be difficult to diagnose. So it necessary to obtain numerous sample from different disease to develop more specific diagnosis kit It could be possible through the characterisation of new genetic biomarkers.Study Status:
Not yet recruiting
Disease:
Parkinson's Disease; Amyotrophic Lateral Sclerosis; Glioblastoma; Cancer Without Neurological Disease; Rheumatoid Polyarthritis
Study Type:
Interventional
Type of Intervention:
Biological
Intervention Name:
Collection of biological sample (blood and/or CSF)
Placebo:
No
Phase:
N/A
Study Chair(s)/Principal Investigator(s):
Jerome Honnorat, Pr, Centre de référence des syndromes neurologiques paranéoplasiques et encéphalites auto-immunes, Lyon, France
Clinicaltrials.gov ID:
Neals Affiliated?
No
Coordinating Center Contact Information
Jerome Honnorat, Pr / email hidden; JavaScript is required / (33) 4 72 35 78 06
Study Sponsor:
Hospices Civils de Lyon
Estimated Enrollment:
350
Estimated Study Start Date:
09 / 16 / 2022
Estimated Study Completion Date:
09 / 16 / 2027
Posting Last Modified Date:
09 / 14 / 2022
Date Study Added to neals.org:
05 / 11 / 2022
Minimum Age:
18 Years
Maximum Age:
N/A
Inclusion Criteria:- patient with consent
- patient with following disease: Parkinson's disease, Amyotrophic lateral sclerosis, Glioblastoma, cancer without neurological disease (pulmonary cancer, breast cancer, ovarian cancer, melanoma, thymoma), rheumatoid arthritis.
Exclusion Criteria:
- refusal consent
- patient with neurological disorder compatible with paraneoplastic neurological syndrome or auto-immune encephalitis
- patient under guardianship
Hospices Civils de Lyon
Jerome HONNORAT, Pr / (33) 4 72 35 78 06 / email hidden; JavaScript is required
Principal Investigator : Jerome HONNORAT
Bron 69500
France